Two Sigma Securities, LLC Abb Vie Inc. Put Options Transaction History

Two Sigma Securities, LLC

$5.78 Billion
Q3 2024

Put Options

26 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	SELL	$163.84 - $199.33 $16.1 Million - $19.6 Million	-98,400 Reduced 62.72%	58,500 $11.6 Million
Q2 2024 Aug 14, 2024	SELL	$154.79 - $180.76 $15 Million - $17.5 Million	-96,900 Reduced 38.18%	156,900 $26.9 Million
Q1 2024 May 15, 2024	BUY	$159.82 - $182.1 $28.4 Million - $32.3 Million	177,400 Added 232.2%	253,800 $46.2 Million
Q4 2023 Feb 14, 2024	SELL	$137.6 - $154.97 $23.3 Million - $26.3 Million	-169,600 Reduced 68.94%	76,400 $11.8 Million
Q3 2023 Nov 14, 2023	BUY	$133.59 - $154.65 $21.7 Million - $25.1 Million	162,200 Added 193.56%	246,000 $36.7 Million
Q2 2023 Aug 14, 2023	SELL	$132.51 - $164.9 $18.3 Million - $22.7 Million	-137,800 Reduced 62.18%	83,800 $11.3 Million
Q1 2023 May 15, 2023	BUY	$144.61 - $166.54 $9.93 Million - $11.4 Million	68,700 Added 44.93%	221,600 $35.3 Million
Q4 2022 Feb 14, 2023	BUY	$138.31 - $165.87 $235,127 - $281,979	1,700 Added 1.12%	152,900 $24.7 Million
Q3 2022 Nov 14, 2022	BUY	$134.21 - $153.93 $1.93 Million - $2.22 Million	14,400 Added 10.53%	151,200 $20.3 Million
Q2 2022 Aug 15, 2022	BUY	$137.62 - $174.96 $12.4 Million - $15.7 Million	90,000 Added 192.31%	136,800 $21 Million
Q1 2022 May 16, 2022	BUY	$131.98 - $163.75 $5.91 Million - $7.34 Million	44,800 Added 2240.0%	46,800 $7.59 Million
Q4 2021 Feb 14, 2022	SELL	$107.43 - $135.93 $4.09 Million - $5.18 Million	-38,100 Reduced 95.01%	2,000 $271,000
Q3 2021 Nov 15, 2021	BUY	$106.4 - $120.78 $542,640 - $615,978	5,100 Added 14.57%	40,100 $4.33 Million
Q2 2021 Aug 16, 2021	SELL	$105.21 - $117.21 $694,386 - $773,586	-6,600 Reduced 15.87%	35,000 $3.94 Million
Q4 2020 Feb 16, 2021	BUY	$80.49 - $108.67 $2.21 Million - $2.99 Million	27,500 Added 195.04%	41,600 $4.46 Million
Q3 2020 Nov 16, 2020	SELL	$85.91 - $100.83 $352,231 - $413,403	-4,100 Reduced 22.53%	14,100 $1.24 Million
Q2 2020 Sep 10, 2020	SELL	$73.37 - $98.18 $719,026 - $962,164	-9,800 Reduced 35.0%	18,200 $1.79 Million
Q1 2020 May 15, 2020	SELL	$64.5 - $97.79 $12.4 Million - $18.7 Million	-191,500 Reduced 87.24%	28,000 $2.13 Million
Q4 2019 Feb 14, 2020	BUY	$72.13 - $90.25 $1.8 Million - $2.26 Million	25,000 Added 12.85%	219,500 $19.4 Million
Q2 2019 Aug 14, 2019	BUY	$65.7 - $83.98 $11.9 Million - $15.1 Million	180,400 Added 1279.43%	194,500 $14.1 Million
Q1 2019 May 15, 2019	SELL	$77.14 - $90.79 $5 Million - $5.88 Million	-64,800 Reduced 82.13%	14,100 $1.14 Million
Q4 2018 Feb 14, 2019	SELL	$77.85 - $96.01 $5.66 Million - $6.98 Million	-72,700 Reduced 47.96%	78,900 $7.27 Million
Q3 2018 Nov 14, 2018	SELL	$88.91 - $98.84 $7.29 Million - $8.1 Million	-82,000 Reduced 35.1%	151,600 $14.3 Million
Q2 2018 Aug 14, 2018	SELL	$89.78 - $106.23 $14.2 Million - $16.8 Million	-158,000 Reduced 40.35%	233,600 $21.6 Million
Q1 2018 May 15, 2018	BUY	$92.01 - $123.21 $35.6 Million - $47.7 Million	387,300 Added 9006.98%	391,600 $37.1 Million
Q4 2017 Feb 14, 2018	BUY	$89.56 - $98.21 $385,108 - $422,303	4,300	4,300 $416,000

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Securities, LLC with notifications on news.

Account